Bavarian Nordic — Oktober 2016
-
Min kommentar på Zealand Pharma på Børsen Play.
https://play.borsen.dk/social/57f36a5fd99b63192e1f5c01 -
må lige høre det senere idag når der bliver tid.
-
Ja, men under forudsætning af at Prostvac godkendes!
-
Bava i mioklub http://www.radio24syv.dk/programmer/millionaerklubben/14626175/millionaerklubben-06-10-2016/
Med Investor Relation-chef Rolf Sass Sørensen
De 3 vigtigste kandidater i pipeline:
RSVaccine (fase 2 begynder 'snart')
CV301 (vaccine til flere cancertyper fase 2 begynder i 2016)
Prostvac (er i fase 3, endeligt resultat i 2017, men delresultat omkring nytår)
Derudover er der koppevaccine/imvamune, der bliver solgt i dag.
Ebolavaccine er i fase 3. Sika ligger langt fremme i tiden. -
-
Fin artikel i Børsen. (Hos Michael Voss og Fundamental Invest fylder Bavarian også en del)
:
http://borsen.dk/nyheder/avisen/artikel/11/153454/artikel.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind